Source: Annual Congress 2010 - Novel markers of lung injury
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
U. Farkhutdinov, S. Farkhutdinov, A. Mirchaidarov, V. Petryakov (Ufa, Russian Federation). The role of free radical processes in lung diseases. Eur Respir J 2010; 36: Suppl. 54, 1808

Member's Comments

No comment yet.

Related content which might interest you: The process of free radical oxidation in patients with lung disorders Source: Annual Congress 2007 - Lung injury and repair: from in vitro to in vivo Year: 2007 Free radical processes and their correction in patients with lung diseases Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 What shall we do with the damaged proteins in lung disease? Ask the proteasome! Source: Eur Respir J 2012; 40: 1260-1268 Year: 2012 Development of new treatments for complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Effects of histamine on free radical homeostasis in patients with atopic diseases Source: Eur Respir J 2001; 18: Suppl. 33, 433s Year: 2001 Effects of aerosol treatment with oxidized glutathione on free radical oxidation processes in case of experimental chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 170s Year: 2002 The role of peroxiredoxins in the radiation-induced damage of lung cancer cells Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 The role of macrophages in interstitial lung diseases Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017 Year: 2017 Cellular interactions in the pathogenesis of interstitial lung diseases Source: Eur Respir Rev 2015; 24: 102-114 Year: 2015 Cellular mechanisms of paediatric lung disease Source: Virtual Congress 2020 – Paediatric year in review Year: 2020 Impaired oxidant/antioxidant balance and relationships between inflammatory markers and antioxidants in patients with primary lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 86s Year: 2006 The terms of adaptation of functional systems of patients with lung cancer and secondary inflammatory changes after surgical treatment Source: Eur Respir J 2006; 28: Suppl. 50, 750s Year: 2006 The role of prooxidant effect of metals with variable valiancy in pathogenesis of chronic obstructive diseases of lungs Source: Eur Respir J 2002; 20: Suppl. 38, 96s Year: 2002 Desferrioxamine attenuates minor lung injury following surgical acute liver failure Source: Eur Respir J 2009; 33: 1429-1436 Year: 2009 The role of lipoxin A4 and its receptor in pathogenesis of inflammatory lung diseases Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Indicators of increased free radical activity in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003 The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006 The pathomechanistic role of autophagy in lung fibrosis Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017